Timothy A. Chan MD, PhD is Chair of the Global Center for Immunotherapy and Precision Immuno-Oncology (CITI) at the Cleveland Clinic. Department Chair of Cancer Sciences and principal investigator of his own cancer research laboratory. CITI is an institution focused on immunotherapy research and translational sciences that brings together multidisciplinary experts from across the Clinic enterprise to advance research and treatment related to the rapidly growing field of immuno-oncology. He is co-director of the National Center for Regenerative Medicine and a program director of the Case Comprehensive Cancer Center Immuno-Oncology Program. He is an internationally recognized expert in precision immuno-oncology and a pioneer in using genomics to determine which patients will respond best to certain types of immunotherapies. He has published over 200 articles in peer-reviewed journals, made landmark discoveries in his field and received numerous awards, including the National Cancer Institute Outstanding Investigator Award in 2018.The focus of the Chan laboratory is to understand the genomic basis of tumor development and treatment response. They use both large-scale genomic analyses and functional dissection to determine what drives oncogenesis. From this information, they seek to develop improved diagnostic and therapeutic modalities for human cancers.Dr. Chan earned his MD and PhD in genetics from Johns Hopkins University, where he also completed a residency in radiation oncology and a postdoctoral fellowship in the division of tumor biology. He is board certified in radiation oncology and is an elected member of the Association of American Physicians. Dr. Chan was previously at the Memorial Sloan Kettering for over a decade. He is also a member of the National Academy of Medicine.Dr. Chan also collaborates with experts in the Center for Global and Emerging Pathogens Research, which is focused on broadening understanding of immunology and microbial pathogenesis with the goal of improving treatment for a variety of diseases, including virus-induced cancers.
